<DOC>
	<DOCNO>NCT01640496</DOCNO>
	<brief_summary>The purpose study test blood tissue sample people Ulcerative Colitis ( UC ) see effect Vitamin D3 may immune system . This research do could lead development new treatment people Inflammatory Bowel Disease ( IBD ) .</brief_summary>
	<brief_title>Vitamin D Treatment Ulcerative Colitis</brief_title>
	<detailed_description>The primary endpoint trial change colonic permeability global assessment vitamin D3 effect throughout colon patient Ulcerative Colitis . Secondary endpoint change colonic tight junction protein expression , relationship serum vitamin D level , VDR expression , inflammatory cytokine , histologic inflammation</detailed_description>
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis , Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Inflammatory Bowel Diseases</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin D</mesh_term>
	<mesh_term>Ergocalciferols</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>Patients must 18 year age diagnosis UC confirm histology . UC patient must active mild disease confirm Mayo Clinic endoscopy score 24 , require medication adjustment trial . Patients must capable understand purpose , risk expectation study participation willing provide write informed consent . Individuals vitamin D laxative therapy ( except purpose endoscopy preparation ) , UC patient fulminant colitis active C difficile colonic infection , age &lt; 18 year old , individual bleed disorder exclude study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>Ulcerative Colitis</keyword>
	<keyword>Inflammatory Bowel disease</keyword>
	<keyword>IBD</keyword>
	<keyword>Vitamin D</keyword>
</DOC>